DMCC Speciality Chemicals Ltd
DMCCDMCC Speciality Chemicals Ltd's earnings have outrun its stock. EPS grew +27.0% in a year against a −16.3% price move.
The sharpest disagreement: annual EPS moved +27.0% against a −16.3% price move — the market has not yet caught up with the delivery.
The price is topping out (8 weeks in) while the P/E sits at the 36th percentile of its own 9-year range. Underneath, the last four quarters read improving — profit +18.2% year on year, and 95% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
DMCC Speciality Chemicals Ltd trades at ₹263, losing momentum at the top and 8 weeks into that stage. That is −0.1% against its own 200-day average. It sits at 49% of a 52-week range of ₹207 to ₹321. On relative strength it is currently behind the NIFTY 500 on a trailing-13-week view (6 weeks and counting).
Today the stock is losing momentum at the top — week 8 of stage 3, confirmed. At ₹263 it trades −0.1% versus its 200-day average and sits at 49% of its 52-week range (₹207–₹321).
Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +353% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (6 weeks and counting; last ahead the week of 2026-06-19) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 36th percentile of its own range.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
DMCC Speciality Chemicals Ltd trades at 24.9× P/E, mid-range by its own standards (36th percentile). Its long-run median P/E is 28.8×, measured across 8.6 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 24.9× is mid-range by its own standards (36th percentile), against a long-run median of 28.8× measured over 8.6 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +27.0% against a −16.3% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 5y, of the −6.5%/yr price move, ~−3.4%/yr came from earnings growth and ~−3.1 pp from the multiple (compressing). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.
Stage: Mixed Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
DMCC Speciality Chemicals Ltd reads as mixed on its fundamental arc. Mixed — no clean majority across the growth curves, ROCE lifting at 15.0% — the per-curve reads carry the story. The read is built from 10 quarters across 3 curves, on partial evidence.
Why it matters: when the curves disagree, the per-curve reads above matter more than any single verdict.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
A partial read: at least one curve is short, or the returns curve is not the computed quarterly series — hold the stage word a little more loosely.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +35.0% | +14.6% | +23.8% | — |
| Profit | +22.7% | +56.8% | −3.9% | — |
| EPS | +27.0% | +58.0% | −3.4% | — |
| Share price | −16.3% | −4.9% | −6.5% | +13.7% |
→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.
4-Factor Sector Score
45.7/100 — rank 17 of 27 in Speciality Chemicals · 76% evidence confidence
DMCC Speciality Chemicals Ltd scores 45.7 out of 100 against the 27 companies it is compared with in Speciality Chemicals, ranking 17. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 20.4 + 11 + 10.5 + 3.8 = 45.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
DMCC Speciality Chemicals Ltd reported ₹178 Cr of revenue in the Mar 26 quarter, +41.9% year on year. That is the 7th straight quarter of year-on-year growth. Over 9 years it has compounded at 14.3% a year. The last full year, FY26, came in at ₹582 Cr. The last four reported quarters add to ₹582 Cr.
DMCC Speciality Chemicals Ltd reported ₹178 Cr of revenue in the Mar 26 quarter, +41.9% year on year. That is the 7th straight quarter of year-on-year growth. Over 9 years it has compounded at 14.3% a year. The last full year, FY26, came in at ₹582 Cr. The last four reported quarters add to ₹582 Cr.
FY26 revenue came in at ₹582 Cr (+35.0% on the year), capping 9 years at 14.3% compound. The latest quarter (Mar 26) printed ₹178 Cr, +41.9% year on year — the 7th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +35.3% growth against the decade's 14.3% — the current year is running faster than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +34.8% over the last 4 quarters against +33.4%/yr over the last 8 — stabilising; TTM profit +27.0% vs +53.6%/yr — rolling over.
→ Revenue grew — did margins hold as it scaled? Next: 10.0% this quarter (−2.1 pp YoY).
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
DMCC Speciality Chemicals Ltd's operating margin is 10.0% in the Mar 26 quarter, −2.1 percentage points against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 9.0% to 24.0%. The current quarter sits inside that band.
DMCC Speciality Chemicals Ltd's operating margin is 10.0% in the Mar 26 quarter, −2.1 percentage points against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 9.0% to 24.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 10.0%, −2.1 pp against the same quarter a year ago. Across 10 fiscal years the operating margin has ranged 9.0%–24.0%.
🚨 Why the margin moved: operating margin went −2.1 pp year on year while gross margin went −9.0 pp — the loss came mostly from the gross line: input costs and pricing.
→ Margins slipped — did that reach the bottom line? Next: profit +18.2% in the latest quarter.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
DMCC Speciality Chemicals Ltd earned ₹7.7 Cr of net profit in the Mar 26 quarter, +18.2% year on year. Full-year FY26 profit was ₹27.0 Cr. The 9-year compound rate is 5.3%. That is 4.3% of the quarter's revenue. The same quarter a year earlier earned ₹6.5 Cr.
DMCC Speciality Chemicals Ltd earned ₹7.7 Cr of net profit in the Mar 26 quarter, +18.2% year on year. Full-year FY26 profit was ₹27.0 Cr. The 9-year compound rate is 5.3%. That is 4.3% of the quarter's revenue. The same quarter a year earlier earned ₹6.5 Cr.
Mar 26 profit was ₹7.7 Cr, +18.2% year on year. On the full year, FY26 printed ₹27.0 Cr (+22.7%), and the 9-year compound rate is 5.3%.
Why profit moved: revenue contributed +41.9% and the margin −2.1 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit +115.5% vs revenue +35.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
→ Profit rose — but did the cash follow? Next: 95% of the last 3 years' profit arrived as cash.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 95% of DMCC Speciality Chemicals Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY26 that was ₹−18.0 Cr of operating cash against ₹27.0 Cr of profit. After ₹7.0 Cr of capital spending, ₹−25.0 Cr was left as free cash.
FY26: operating cash of ₹−18.0 Cr against reported profit of ₹27.0 Cr, leaving free cash of ₹−25.0 Cr after ₹7.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 95% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why conversion sits at 95%: the cash cycle held roughly steady between FY21 and FY26 — so conversion tracks profitability rather than the cycle.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
→ So follow the cash to where it goes. Next: a 83-day cycle and ₹33.0 Cr of building.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
DMCC Speciality Chemicals Ltd's cash conversion cycle runs 83 days in FY26, down from 92 days in FY21. Capital spending ran ₹33.0 Cr over the last 3 years. At FY26 sales of ₹582 Cr each day of that cycle holds about ₹1.6 Cr, so roughly ₹132 Cr sits inside the business at any moment.
FY26: debtors at 60 days, inventory at 82 days — roughly 2.7 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 83 days, tighter than FY21's 92.
The full loop: cash goes out to suppliers and production on day 0; stock waits 82 days to sell; customers pay about 60 days after that; and suppliers themselves are paid at 59 days — netting out to the 83-day cycle.
In money terms: at FY26 sales of ₹582 Cr, each day of the cycle holds about ₹1.6 Cr — so the 83-day loop keeps roughly ₹132 Cr sitting inside the business at any moment.
On the investment side: capital spending of ₹33.0 Cr over the last 3 fiscal years against ₹49.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹5.0 Cr (FY26) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
→ Does all this activity actually earn its cost of capital? Next: ROCE is 15% and the ROIC − WACC spread is −0.9 pp.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
DMCC Speciality Chemicals Ltd earns a ROCE of 15% in FY26. That is up from a trough of 7% in FY23. Return on invested capital clears the cost of that capital by −0.9 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is 4.6% net margin on 1.30× asset turns.
FY26 ROCE is 15%, recovered from a FY23 trough of 7% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY26): 4.6% net margin × 1.30× asset turns × 1.80× balance-sheet leverage ≈ 10.8% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 11.1% − 12.0% = a −0.9 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.35.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
DMCC Speciality Chemicals Ltd carries total debt of ₹87.0 Cr against shareholder equity of ₹248 Cr as of Mar 26, a debt-to-equity of 0.35. On the annual view that ratio went from 0.48 in FY22 to 0.35 in FY26. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of ₹87.0 Cr against shareholder equity of ₹248 Cr — a debt-to-equity of 0.35. On the annual view, debt-to-equity went from 0.48 (FY22) to 0.35 (FY26). Read the returns on this page with that leverage in mind.
→ Who owns this, and are they adding or leaving? Next: the register is quiet.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
No holder of DMCC Speciality Chemicals Ltd moved a full percentage point over the last two years — the register is quiet. Foreign institutions moved +0.1 points over the same window, to 0.1%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +0.3 points over 8 quarters to 1.5%; Foreign institutions: +0.1 points over 8 quarters to 0.1%; Promoters: +0.0 points over 8 quarters to 53.8%.
→ One last check: does the safety math agree? Next: the balance-sheet safety line.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
DMCC Speciality Chemicals Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | P/E | Mkt cap | Revenue | EPS | ROCE | Stage |
|---|---|---|---|---|---|---|
| DMCC Speciality Chemicals Ltd this page | 24.9× | ₹680 Cr | Mixed | |||
| Pidilite Industries Ltd | 64.9× | ₹1.6L Cr | Consistent | |||
| Aether Industries Ltd | 83.7× | ₹18,945 Cr | Mixed | |||
| Aarti Industries Ltd | 42.1× | ₹17,331 Cr | Turning around | |||
| Anupam Rasayan India Ltd | 83.6× | ₹14,226 Cr | Improving | |||
| Privi Speciality Chemicals Ltd | 42.9× | ₹14,044 Cr | Mixed | |||
| Vinati Organics Ltd | 30.4× | ₹13,478 Cr | Topping out | |||
| Alkyl Amines Chemicals Ltd | 48.3× | ₹9,153 Cr | No read | |||
| Clean Science & Technology Ltd | 33.4× | ₹7,663 Cr | Deteriorating | |||
| Galaxy Surfactants Ltd | 24.8× | ₹6,896 Cr | Mixed | |||
| Neogen Chemicals Ltd | 159.0× | ₹5,648 Cr | Mixed | |||
| Fineotex Chemical Ltd | 37.7× | ₹4,610 Cr | Turning around | |||
| Vishnu Chemicals Ltd | 29.9× | ₹4,257 Cr | Mixed | |||
| Tatva Chintan Pharma Chem Ltd | 76.9× | ₹4,029 Cr | Turning around | |||
| Yasho Industries Ltd | 147.0× | ₹3,704 Cr | Improving | |||
| Grauer & Weil (India) Ltd | 20.4× | ₹3,354 Cr | Turning around | |||
| Panama Petrochem Ltd | 14.2× | ₹3,014 Cr | Turning around | |||
| Fineotex Chemical Ltd | 28.3× | ₹2,551 Cr | Turning around | |||
| Thirumalai Chemicals Ltd | — | ₹2,022 Cr | No read | |||
| Paushak Ltd | 41.6× | ₹1,387 Cr | Mixed | |||
| Platinum Industries Ltd | 23.9× | ₹1,251 Cr | Improving | |||
| Amines & Plasticizers Ltd | 29.3× | ₹1,069 Cr | Topping out | |||
| Sunshield Chemicals Ltd | 35.5× | ₹1,051 Cr | Turning around | |||
| Vikram Thermo (India) Ltd | 20.0× | ₹768 Cr | Mixed | |||
| Sunshield Chemicals Ltd | 29.2× | ₹720 Cr | Turning around | |||
| Chemcon Speciality Chemicals Ltd | 27.4× | ₹647 Cr | Improving | |||
| Amal Ltd | 23.0× | ₹628 Cr | No read | |||
| Transpek Industry Ltd | 13.0× | ₹595 Cr | Deteriorating | |||
| Kronox Lab Sciences Ltd | 20.7× | ₹573 Cr | Mixed |
Frequently asked questions
What is DMCC Speciality Chemicals Ltd's share price today?
DMCC Speciality Chemicals Ltd trades at ₹263, −16.3% over the past year. The company is valued at ₹680 Cr. The stock sits at 49% of its 52-week range of ₹207–₹321, −0.1% versus its 200-day average. On the tape, the price is topping out, 8 weeks in. — as of 24 July 2026.
What were DMCC Speciality Chemicals Ltd's latest quarterly results?
DMCC Speciality Chemicals Ltd reported revenue of ₹178 Cr and net profit of ₹7.7 Cr for the Mar 26 quarter. Revenue rose 41.9% and profit rose 18.2% year on year. Earnings per share were ₹3.07. The operating margin was 10.0%, 2.1 pp lower than a year earlier. — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's revenue?
DMCC Speciality Chemicals Ltd reported revenue of ₹178 Cr in the Mar 26 quarter, +41.9% year on year. For the full FY26 fiscal year, revenue was ₹582 Cr (+35.0%). Over the last 9 years revenue compounded at 14.3% a year. — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's profit?
DMCC Speciality Chemicals Ltd earned ₹7.7 Cr of net profit in the Mar 26 quarter, +18.2% year on year. Full-year FY26 profit was ₹27.0 Cr. The operating margin ran 10.0% in the latest quarter. — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's market cap?
DMCC Speciality Chemicals Ltd's market capitalisation is ₹680 Cr at a share price of ₹263. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's P/E ratio?
DMCC Speciality Chemicals Ltd trades at a P/E of 24.9×, at the 36th percentile of its own 9-year range, against a long-run median of 28.8×. This is a comparison with the stock's own history, not a value call — as of 24 July 2026.
Does DMCC Speciality Chemicals Ltd pay a dividend?
Yes — DMCC Speciality Chemicals Ltd's dividend payout was 23% of profit in FY26, and it recorded a payout in 7 of its last 10 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd overvalued?
On its own history, DMCC Speciality Chemicals Ltd looks mid-range against its own history: its P/E of 24.9× sits at the 36th percentile of its 9-year range (long-run median 28.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd growing?
Yes — DMCC Speciality Chemicals Ltd is growing: latest-quarter revenue +41.9% year on year, profit +18.2%, and the margin −2.1 pp at 10.0%. The 9-year compound rates are 14.3% (revenue) and 5.3% (profit). The earnings engine currently reads: improving — as of 24 July 2026.
How is DMCC Speciality Chemicals Ltd performing?
DMCC Speciality Chemicals Ltd is topping out, 8 weeks in. Its latest quarter's revenue rose 41.9% and profit rose 18.2% year on year. Against the NIFTY 500 it has been behind on a trailing-13-week view for 6 weeks. This describes what the data did, not a rating. — as of 24 July 2026.
What stage is DMCC Speciality Chemicals Ltd in?
Mixed — no clean majority across the growth curves, ROCE lifting at 15.0% — the per-curve reads carry the story. The read comes from the last 12 quarters of growth (revenue growth +41.9% latest, profit growth +18.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd in an uptrend?
It is stalling — the price is topping out (week 8 of stage 3), trading −0.1% versus its 200-day average and at 49% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd beating the market?
Not lately — on a trailing-13-week view DMCC Speciality Chemicals Ltd is currently behind the NIFTY 500 (6 weeks and counting; last ahead the week of 2026-06-19), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.3 years the stock moved +353% against the NIFTY 500's +274% — ahead of the index over the full window. — as of 24 July 2026.
Will DMCC Speciality Chemicals Ltd's share price go up?
This page publishes no price forecast for DMCC Speciality Chemicals Ltd. What it measures instead: the share price is ₹263, the price is topping out 8 weeks in. Its P/E of 24.9× sits at the 36th percentile of its own 9-year range. — as of 24 July 2026.
Who owns DMCC Speciality Chemicals Ltd?
Promoters hold 53.8% of DMCC Speciality Chemicals Ltd, foreign institutions 0.1%, domestic institutions 1.5% and the public 44.5% (latest quarter). No holder moved a full point over the last two years — the register is quiet. — as of 24 July 2026.
Does DMCC Speciality Chemicals Ltd have too much debt?
It is moderate — DMCC Speciality Chemicals Ltd's debt-to-equity is 0.35, and operating profit covers the interest bill 6×. FY26 borrowings were ₹87.0 Cr against equity of ₹248 Cr. Read the returns on this page with that leverage in mind — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's capex?
DMCC Speciality Chemicals Ltd spent ₹33.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY26 alone that was ₹7.0 Cr, with ₹5.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 24 July 2026.
What is DMCC Speciality Chemicals Ltd's cash flow?
DMCC Speciality Chemicals Ltd generated ₹−18.0 Cr of operating cash flow in FY26 and ₹−25.0 Cr of free cash flow after ₹7.0 Cr of capital spending. Reported profit that year was ₹27.0 Cr, so operating cash ran behind profit. Cash-flow resolution for India is annual. — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd's profit real cash?
Yes — over the last 3 fiscal years, 95% of DMCC Speciality Chemicals Ltd's reported profit arrived as operating cash. In FY26, operating cash was ₹−18.0 Cr against reported profit of ₹27.0 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 24 July 2026.
Where is DMCC Speciality Chemicals Ltd in its business cycle?
DMCC Speciality Chemicals Ltd's FY26 operating margin was 11.0%, against a 10-year band of 9.0%–24.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 10.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 24 July 2026.
What could break the DMCC Speciality Chemicals Ltd story?
The sharpest disagreement: annual EPS moved +27.0% against a −16.3% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 24 July 2026.
Is DMCC Speciality Chemicals Ltd a stock worth studying right now?
This is not investment advice. The machine read: DMCC Speciality Chemicals Ltd's earnings have outrun its stock. EPS grew +27.0% in a year against a −16.3% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 24 July 2026.